TABLE OF CONTENTS 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Dermatological Drugs 1.2 Key Market Segments 1.2.1 Dermatological Drugs Segment by Type 1.2.2 Dermatological Drugs Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Dermatological Drugs Market Overview 2.1 Global Market Overview 2.1.1 Global Dermatological Drugs Market Size (M USD) Estimates and Forecasts (2017-2028) 2.1.2 Global Dermatological Drugs Sales Estimates and Forecasts (2017-2028) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Dermatological Drugs Market Competitive Landscape 3.1 Global Dermatological Drugs Sales by Manufacturers (2017-2022) 3.2 Global Dermatological Drugs Revenue Market Share by Manufacturers (2017-2022) 3.3 Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4 Global Dermatological Drugs Average Price by Manufacturers (2017-2022) 3.5 Manufacturers Dermatological Drugs Sales Sites, Area Served, Product Type 3.6 Dermatological Drugs Market Competitive Situation and Trends 3.6.1 Dermatological Drugs Market Concentration Rate 3.6.2 Global 5 and 10 Largest Dermatological Drugs Players Market Share by Revenue 3.6.3 Mergers & Acquisitions, Expansion 4 Dermatological Drugs Industry Chain Analysis 4.1 Dermatological Drugs Industry Chain Analysis 4.2 Market Overview and Market Concentration Analysis of Key Raw Materials 4.3 Midstream Market Analysis 4.4 Downstream Customer Analysis 5 The Development and Dynamics of Dermatological Drugs Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 New Product Developments 5.5.2 Mergers & Acquisitions 5.5.3 Expansions 5.5.4 Collaboration/Supply Contracts 5.6 Industry Policies 6 Dermatological Drugs Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global Dermatological Drugs Sales Market Share by Type (2017-2022) 6.3 Global Dermatological Drugs Market Size Market Share by Type (2017-2022) 6.4 Global Dermatological Drugs Price by Type (2017-2022) 7 Dermatological Drugs Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global Dermatological Drugs Market Sales by Application (2017-2022) 7.3 Global Dermatological Drugs Market Size (M USD) by Application (2017-2022) 7.4 Global Dermatological Drugs Sales Growth Rate by Application (2017-2022) 8 Dermatological Drugs Market Segmentation by Region 8.1 Global Dermatological Drugs Sales by Region 8.1.1 Global Dermatological Drugs Sales by Region 8.1.2 Global Dermatological Drugs Sales Market Share by Region 8.2 North America 8.2.1 North America Dermatological Drugs Sales by Country 8.2.2 U.S. 8.2.3 Canada 8.2.4 Mexico 8.3 Europe 8.3.1 Europe Dermatological Drugs Sales by Country 8.3.2 Germany 8.3.3 France 8.3.4 U.K. 8.3.5 Italy 8.3.6 Russia 8.4 Asia Pacific 8.4.1 Asia Pacific Dermatological Drugs Sales by Region 8.4.2 China 8.4.3 Japan 8.4.4 South Korea 8.4.5 India 8.4.6 Southeast Asia 8.5 South America 8.5.1 South America Dermatological Drugs Sales by Country 8.5.2 Brazil 8.5.3 Argentina 8.5.4 Columbia 8.6 Middle East and Africa 8.6.1 Middle East and Africa Dermatological Drugs Sales by Region 8.6.2 Saudi Arabia 8.6.3 UAE 8.6.4 Egypt 8.6.5 Nigeria 8.6.6 South Africa 9 Key Companies Profiled 9.1 Johnson and Johnson 9.1.1 Johnson and Johnson Dermatological Drugs Basic Information 9.1.2 Johnson and Johnson Dermatological Drugs Product Overview 9.1.3 Johnson and Johnson Dermatological Drugs Product Market Performance 9.1.4 Johnson and Johnson Business Overview 9.1.5 Johnson and Johnson Dermatological Drugs SWOT Analysis 9.1.6 Johnson and Johnson Recent Developments 9.2 Merck 9.2.1 Merck Dermatological Drugs Basic Information 9.2.2 Merck Dermatological Drugs Product Overview 9.2.3 Merck Dermatological Drugs Product Market Performance 9.2.4 Merck Business Overview 9.2.5 Merck Dermatological Drugs SWOT Analysis 9.2.6 Merck Recent Developments 9.3 Bayer 9.3.1 Bayer Dermatological Drugs Basic Information 9.3.2 Bayer Dermatological Drugs Product Overview 9.3.3 Bayer Dermatological Drugs Product Market Performance 9.3.4 Bayer Business Overview 9.3.5 Bayer Dermatological Drugs SWOT Analysis 9.3.6 Bayer Recent Developments 9.4 Mylan Pharmaceuticals 9.4.1 Mylan Pharmaceuticals Dermatological Drugs Basic Information 9.4.2 Mylan Pharmaceuticals Dermatological Drugs Product Overview 9.4.3 Mylan Pharmaceuticals Dermatological Drugs Product Market Performance 9.4.4 Mylan Pharmaceuticals Business Overview 9.4.5 Mylan Pharmaceuticals Dermatological Drugs SWOT Analysis 9.4.6 Mylan Pharmaceuticals Recent Developments 9.5 Pfizer 9.5.1 Pfizer Dermatological Drugs Basic Information 9.5.2 Pfizer Dermatological Drugs Product Overview 9.5.3 Pfizer Dermatological Drugs Product Market Performance 9.5.4 Pfizer Business Overview 9.5.5 Pfizer Dermatological Drugs SWOT Analysis 9.5.6 Pfizer Recent Developments 9.6 F. Hoffmann-La Roche 9.6.1 F. Hoffmann-La Roche Dermatological Drugs Basic Information 9.6.2 F. Hoffmann-La Roche Dermatological Drugs Product Overview 9.6.3 F. Hoffmann-La Roche Dermatological Drugs Product Market Performance 9.6.4 F. Hoffmann-La Roche Business Overview 9.6.5 F. Hoffmann-La Roche Recent Developments 9.7 Allergan 9.7.1 Allergan Dermatological Drugs Basic Information 9.7.2 Allergan Dermatological Drugs Product Overview 9.7.3 Allergan Dermatological Drugs Product Market Performance 9.7.4 Allergan Business Overview 9.7.5 Allergan Recent Developments 9.8 Valeant Pharmaceuticals 9.8.1 Valeant Pharmaceuticals Dermatological Drugs Basic Information 9.8.2 Valeant Pharmaceuticals Dermatological Drugs Product Overview 9.8.3 Valeant Pharmaceuticals Dermatological Drugs Product Market Performance 9.8.4 Valeant Pharmaceuticals Business Overview 9.8.5 Valeant Pharmaceuticals Recent Developments 9.9 PharmaDerm Pharmaceuticals 9.9.1 PharmaDerm Pharmaceuticals Dermatological Drugs Basic Information 9.9.2 PharmaDerm Pharmaceuticals Dermatological Drugs Product Overview 9.9.3 PharmaDerm Pharmaceuticals Dermatological Drugs Product Market Performance 9.9.4 PharmaDerm Pharmaceuticals Business Overview 9.9.5 PharmaDerm Pharmaceuticals Recent Developments 9.10 Allergan Inamed Corporation 9.10.1 Allergan Inamed Corporation Dermatological Drugs Basic Information 9.10.2 Allergan Inamed Corporation Dermatological Drugs Product Overview 9.10.3 Allergan Inamed Corporation Dermatological Drugs Product Market Performance 9.10.4 Allergan Inamed Corporation Business Overview 9.10.5 Allergan Inamed Corporation Recent Developments 10 Dermatological Drugs Market Forecast by Region 10.1 Global Dermatological Drugs Market Size Forecast 10.2 Global Dermatological Drugs Market Forecast by Region 10.2.1 North America Market Size Forecast by Country 10.2.2 Europe Dermatological Drugs Market Size Forecast by Country 10.2.3 Asia Pacific Dermatological Drugs Market Size Forecast by Region 10.2.4 South America Dermatological Drugs Market Size Forecast by Country 10.2.5 Middle East and Africa Forecasted Consumption of Dermatological Drugs by Country 11 Forecast Market by Type and by Application (2022-2028) 11.1 Global Dermatological Drugs Market Forecast by Type (2022-2028) 11.1.1 Global Forecasted Sales of Dermatological Drugs by Type (2022-2028) 11.1.2 Global Dermatological Drugs Market Size Forecast by Type (2022-2028) 11.1.3 Global Forecasted Price of Dermatological Drugs by Type (2022-2028) 11.2 Global Dermatological Drugs Market Forecast by Application (2022-2028) 11.2.1 Global Dermatological Drugs Sales (K Units) Forecast by Application 11.2.2 Global Dermatological Drugs Market Size (M USD) Forecast by Application (2022-2028) 12 Conclusion and Key Findings

LIST OF TABLES Table 1. Introduction of the Type Table 2. Introduction of the Application Table 3. Market Size (M USD) Segment Executive Summary Table 4. Dermatological Drugs Market Size (M USD) Comparison by Region (M USD) Table 5. Global Dermatological Drugs Sales (K Units) by Manufacturers (2017-2022) Table 6. Global Dermatological Drugs Sales Market Share by Manufacturers (2017-2022) Table 7. Global Dermatological Drugs Revenue (M USD) by Manufacturers (2017-2022) Table 8. Global Dermatological Drugs Revenue Share by Manufacturers (2017-2022) Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatological Drugs as of 2021) Table 10. Global Market Dermatological Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 11. Manufacturers Dermatological Drugs Sales Sites and Area Served Table 12. Manufacturers Dermatological Drugs Product Type Table 13. Global Dermatological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Mergers & Acquisitions, Expansion Plans Table 15. Industry Chain Map of Dermatological Drugs Table 16. Raw Materials Table 17. Midstream Market Analysis Table 18. Downstream Customer Analysis Table 19. Key Development Trends Table 20. Driving Factors Table 21. Dermatological Drugs Market Challenges Table 22. Market Restraints Table 23. Global Dermatological Drugs Sales by Type (K Units) Table 24. Global Dermatological Drugs Market Size by Type (M USD) Table 25. Global Dermatological Drugs Sales (K Units) by Type (2017-2022) Table 26. Global Dermatological Drugs Sales Market Share by Type (2017-2022) Table 27. Global Dermatological Drugs Market Size (M USD) by Type (2017-2022) Table 28. Global Dermatological Drugs Market Size Share by Type (2017-2022) Table 29. Global Dermatological Drugs Price (USD/Unit) by Type (2017-2022) Table 30. Global Dermatological Drugs Sales (K Units) by Application Table 31. Global Dermatological Drugs Market Size by Application Table 32. Global Dermatological Drugs Sales by Application (2017-2022) & (K Units) Table 33. Global Dermatological Drugs Sales Market Share by Application (2017-2022) Table 34. Global Dermatological Drugs Sales by Application (2017-2022) & (M USD) Table 35. Global Dermatological Drugs Market Share by Application (2017-2022) Table 36. Global Dermatological Drugs Sales Growth Rate by Application (2017-2022) Table 37. Global Dermatological Drugs Sales by Region (2017-2022) & (K Units) Table 38. Global Dermatological Drugs Sales Market Share by Region (2017-2022) Table 39. North America Dermatological Drugs Sales by Country (2017-2022) & (K Units) Table 40. Europe Dermatological Drugs Sales by Country (2017-2022) & (K Units) Table 41. Asia Pacific Dermatological Drugs Sales by Region (2017-2022) & (K Units) Table 42. South America Dermatological Drugs Sales by Country (2017-2022) & (K Units) Table 43. Middle East and Africa Dermatological Drugs Sales by Region (2017-2022) & (K Units) Table 44. Johnson and Johnson Dermatological Drugs Basic Information Table 45. Johnson and Johnson Dermatological Drugs Product Overview Table 46. Johnson and Johnson Dermatological Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 47. Johnson and Johnson Business Overview Table 48. Johnson and Johnson Dermatological Drugs SWOT Analysis Table 49. Johnson and Johnson Recent Developments Table 50. Merck Dermatological Drugs Basic Information Table 51. Merck Dermatological Drugs Product Overview Table 52. Merck Dermatological Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 53. Merck Business Overview Table 54. Merck Dermatological Drugs SWOT Analysis Table 55. Merck Recent Developments Table 56. Bayer Dermatological Drugs Basic Information Table 57. Bayer Dermatological Drugs Product Overview Table 58. Bayer Dermatological Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 59. Bayer Business Overview Table 60. Bayer Dermatological Drugs SWOT Analysis Table 61. Bayer Recent Developments Table 62. Mylan Pharmaceuticals Dermatological Drugs Basic Information Table 63. Mylan Pharmaceuticals Dermatological Drugs Product Overview Table 64. Mylan Pharmaceuticals Dermatological Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Mylan Pharmaceuticals Business Overview Table 66. Mylan Pharmaceuticals Dermatological Drugs SWOT Analysis Table 67. Mylan Pharmaceuticals Recent Developments Table 68. Pfizer Dermatological Drugs Basic Information Table 69. Pfizer Dermatological Drugs Product Overview Table 70. Pfizer Dermatological Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 71. Pfizer Business Overview Table 72. Pfizer Dermatological Drugs SWOT Analysis Table 73. Pfizer Recent Developments Table 74. F. Hoffmann-La Roche Dermatological Drugs Basic Information Table 75. F. Hoffmann-La Roche Dermatological Drugs Product Overview Table 76. F. Hoffmann-La Roche Dermatological Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. F. Hoffmann-La Roche Business Overview Table 78. F. Hoffmann-La Roche Recent Developments Table 79. Allergan Dermatological Drugs Basic Information Table 80. Allergan Dermatological Drugs Product Overview Table 81. Allergan Dermatological Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. Allergan Business Overview Table 83. Allergan Recent Developments Table 84. Valeant Pharmaceuticals Dermatological Drugs Basic Information Table 85. Valeant Pharmaceuticals Dermatological Drugs Product Overview Table 86. Valeant Pharmaceuticals Dermatological Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. Valeant Pharmaceuticals Business Overview Table 88. Valeant Pharmaceuticals Recent Developments Table 89. PharmaDerm Pharmaceuticals Dermatological Drugs Basic Information Table 90. PharmaDerm Pharmaceuticals Dermatological Drugs Product Overview Table 91. PharmaDerm Pharmaceuticals Dermatological Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 92. PharmaDerm Pharmaceuticals Business Overview Table 93. PharmaDerm Pharmaceuticals Recent Developments Table 94. Allergan Inamed Corporation Dermatological Drugs Basic Information Table 95. Allergan Inamed Corporation Dermatological Drugs Product Overview Table 96. Allergan Inamed Corporation Dermatological Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) Table 97. Allergan Inamed Corporation Business Overview Table 98. Allergan Inamed Corporation Recent Developments Table 99. Global Dermatological Drugs Sales Forecast by Region (K Units) Table 100. Global Dermatological Drugs Market Size Forecast by Region (M USD) Table 101. North America Dermatological Drugs Sales Forecast by Country (2022-2028) & (K Units) Table 102. North America Dermatological Drugs Market Size Forecast by Country (2022-2028) & (M USD) Table 103. Europe Dermatological Drugs Sales Forecast by Country (2022-2028) & (K Units) Table 104. Europe Dermatological Drugs Market Size Forecast by Country (2022-2028) & (M USD) Table 105. Asia Pacific Dermatological Drugs Sales Forecast by Region (2022-2028) & (K Units) Table 106. Asia Pacific Dermatological Drugs Market Size Forecast by Region (2022-2028) & (M USD) Table 107. South America Dermatological Drugs Sales Forecast by Country (2022-2028) & (K Units) Table 108. South America Dermatological Drugs Market Size Forecast by Country (2022-2028) & (M USD) Table 109. Middle East and Africa Dermatological Drugs Consumption Forecast by Country (2022-2028) & (Units) Table 110. Middle East and Africa Dermatological Drugs Market Size Forecast by Country (2022-2028) & (M USD) Table 111. Global Dermatological Drugs Sales Forecast by Type (2022-2028) & (K Units) Table 112. Global Dermatological Drugs Market Size Forecast by Type (2022-2028) & (M USD) Table 113. Global Dermatological Drugs Price Forecast by Type (2022-2028) & (USD/Unit) Table 114. Global Dermatological Drugs Sales (K Units) Forecast by Application (2022-2028) Table 115. Global Dermatological Drugs Market Size Forecast by Application (2022-2028) & (M USD) LIST OF FIGURES Figure 1. Product Picture of Dermatological Drugs Figure 2. Data Triangulation Figure 3. Key Caveats Figure 4. Global Dermatological Drugs Market Size (M USD), 2017-2028 Figure 5. Global Dermatological Drugs Market Size (M USD) (2017-2028) Figure 6. Global Dermatological Drugs Sales (K Units) & (2017-2028) Figure 7. Evaluation Matrix of Segment Market Development Potential (Type) Figure 8. Evaluation Matrix of Segment Market Development Potential (Application) Figure 9. Evaluation Matrix of Regional Market Development Potential Figure 10. Dermatological Drugs Market Size (M USD) by Country (M USD) Figure 11. Dermatological Drugs Sales Share by Manufacturers in 2020 Figure 12. Global Dermatological Drugs Revenue Share by Manufacturers in 2020 Figure 13. Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 14. Global Market Dermatological Drugs Average Price (USD/Unit) of Key Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Players: Market Share by Dermatological Drugs Revenue in 2021 Figure 16. Evaluation Matrix of Segment Market Development Potential (Type) Figure 17. Global Dermatological Drugs Market Share by Type Figure 18. Sales Market Share of Dermatological Drugs by Type (2017-2022) Figure 19. Sales Market Share of Dermatological Drugs by Type in 2021 Figure 20. Market Size Share of Dermatological Drugs by Type (2017-2022) Figure 21. Market Size Market Share of Dermatological Drugs by Type in 2020 Figure 22. Evaluation Matrix of Segment Market Development Potential (Application) Figure 23. Global Dermatological Drugs Market Share by Application Figure 24. Global Dermatological Drugs Sales Market Share by Application (2017-2022) Figure 25. Global Dermatological Drugs Sales Market Share by Application in 2021 Figure 26. Global Dermatological Drugs Market Share by Application (2017-2022) Figure 27. Global Dermatological Drugs Market Share by Application in 2020 Figure 28. Global Dermatological Drugs Sales Growth Rate by Application (2017-2022) Figure 29. Global Dermatological Drugs Sales Market Share by Region (2017-2022) Figure 30. North America Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 31. North America Dermatological Drugs Sales Market Share by Country in 2020 Figure 32. U.S. Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 33. Canada Dermatological Drugs Sales (K Units) and Growth Rate (2017-2022) Figure 34. Mexico Dermatological Drugs Sales (Units) and Growth Rate (2017-2022) Figure 35. Europe Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 36. Europe Dermatological Drugs Sales Market Share by Country in 2020 Figure 37. Germany Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 38. France Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 39. U.K. Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 40. Italy Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 41. Russia Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 42. Asia Pacific Dermatological Drugs Sales and Growth Rate (K Units) Figure 43. Asia Pacific Dermatological Drugs Sales Market Share by Region in 2020 Figure 44. China Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 45. Japan Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 46. South Korea Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 47. India Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 48. Southeast Asia Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 49. South America Dermatological Drugs Sales and Growth Rate (K Units) Figure 50. South America Dermatological Drugs Sales Market Share by Country in 2020 Figure 51. Brazil Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 52. Argentina Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 53. Columbia Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 54. Middle East and Africa Dermatological Drugs Sales and Growth Rate (K Units) Figure 55. Middle East and Africa Dermatological Drugs Sales Market Share by Region in 2020 Figure 56. Saudi Arabia Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 57. UAE Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 58. Egypt Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 59. Nigeria Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 60. South Africa Dermatological Drugs Sales and Growth Rate (2017-2022) & (K Units) Figure 61. Global Dermatological Drugs Sales Forecast by Volume (2017-2028) & (K Units) Figure 62. Global Dermatological Drugs Market Size Forecast by Value (2017-2028) & (M USD) Figure 63. Global Dermatological Drugs Sales Market Share Forecast by Type (2022-2028) Figure 64. Global Dermatological Drugs Market Share Forecast by Type (2022-2028) Figure 65. Global Dermatological Drugs Sales Forecast by Application (2022-2028) Figure 66. Global Dermatological Drugs Market Share Forecast by Application (2022-2028)

•Johnson and Johnson •Merck •Bayer •Mylan Pharmaceuticals •Pfizer •F. Hoffmann-La Roche •Allergan •Valeant Pharmaceuticals •PharmaDerm Pharmaceuticals •Allergan Inamed Corporation